Yongming Dai

Experienced magnetic resonance imaging (MRI) professional with 17 years of expertise in clinical research. From 2006 to 2022, I held various positions as MRI sequence development engineer and MR research collaboration director at Siemens (Shenzhen) Magnetic Resonance Limited, Siemens (China) Limited, Philips (China), and Shanghai United Imaging Healthcare Co., Ltd. Currently, I am serving as an Associate Researcher at School of Biomedical Engineering, ShanghaiTech University, focusing on Medical Imaging. My research fields include MR angiography, MR temperature mapping, MR-sensitive weighted body imaging, diffusion modeling, tumor microstructure, spectroscopy imaging, and neonatal brain development. As a director of the MR research collaboration team, I work with domestic clients on clinical research projects. My team consists of excellent professionals with backgrounds in MR, physics, biomedicine, and artificial intelligence. During the COVID-19 pandemic, I led the team to collaborate with Shanghai Public Health Clinical Center and published the world's first article on MR imaging of COVID-19 lungs. I also have successfully developed the application of MR imaging for evaluating the lung function of COVID-19 patients. In recent years, my research has focused on novel diffusion models, tumor microstructure imaging, spectroscopy imaging, and other technologies, which I have worked with Chinese clients to apply in the clinical setting. I have collaborated with top 50 hospitals in China and published over 80 SCI papers. I have built an extensive professional collaboration network and cultivated MR research talents with distinct technical characteristics.